Department of Epidemiology, The University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
Department of Microbiology and Immunology, The University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
mBio. 2022 Jun 28;13(3):e0038622. doi: 10.1128/mbio.00386-22. Epub 2022 Apr 28.
Maturation of dengue viruses (DENVs) alters the structure, immunity, and infectivity of the virion and highly mature particles represent the dominant form . The production of highly mature virions principally relies on the structure and function of the viral premature membrane protein (prM) and its cleavage by the host protease furin. We redeveloped a reliable clonal cell line (VF1) which produces single-round mature DENVs without the need for DENV reverse genetics. More importantly, using protein engineering and directed evolution of the prM cleavage site, we engineered genetically stable mature DENVs in all serotypes independent of cell or host, usually with minimal impact on viral yield. Using these complementary strategies to regulate maturation, we demonstrate that the resulting mature DENVs are antigenically distinct from their isogenic partially mature forms. Given the clinical importance of mature DENVs in immunity, our study provides reliable strategies and reagents for the production of stable, high-titer mature DENVs for DENV antibody neutralization and vaccination immunity studies. Biologically, our data from directed evolution across host species reveals distinct maturation-dependent selective pressures between mammalian and insect cells, verifying the substrate preference between mammalian and insect furin, while hinting at an evolutionary equilibrium of DENV prM cleavage site between its host and vector in nature. Mature DENVs represent the dominant form and are the target for vaccine development. Here, we used multiple strategies, including protein engineering and natural and directed evolution to generate DENV1, -2, -3, and -4 variants that are highly mature without compromising replication efficiency compared to the parental strains. Given the clinical importance of mature DENVs in immunity, this work provides a roadmap for engineering highly mature DENV that could apply to future vaccine development. Our directed-evolution data also shed light on the divergent evolutionary relationship of DENVs between its host and vector.
登革病毒(DENV)的成熟会改变病毒粒子的结构、免疫原性和感染力,高度成熟的粒子是主要形式。高度成熟病毒粒子的产生主要依赖于病毒前膜蛋白(prM)的结构和功能及其被宿主蛋白酶弗林的切割。我们重新开发了一种可靠的克隆细胞系(VF1),该细胞系无需 DENV 反向遗传学即可产生单轮成熟的 DENV。更重要的是,通过对 prM 切割位点的蛋白质工程和定向进化,我们在所有血清型中独立于细胞或宿主工程了遗传稳定的成熟 DENV,通常对病毒产量的影响最小。使用这些互补的调控成熟的策略,我们证明了所得成熟 DENV 在抗原性上与其同基因部分成熟形式不同。鉴于成熟 DENV 在免疫中的临床重要性,我们的研究为生产稳定、高滴度的成熟 DENV 提供了可靠的策略和试剂,用于 DENV 抗体中和和疫苗免疫研究。从跨宿主物种的定向进化获得的数据表明,哺乳动物和昆虫细胞之间存在不同的成熟依赖性选择压力,验证了哺乳动物和昆虫弗林之间的底物偏好,同时暗示 DENV prM 切割位点在其自然宿主和媒介之间存在进化平衡。成熟的 DENV 是主要形式,是疫苗开发的目标。在这里,我们使用了多种策略,包括蛋白质工程以及自然和定向进化,生成了与亲本株相比复制效率不受影响但高度成熟的 DENV1、-2、-3 和 -4 变体。鉴于成熟 DENV 在免疫中的临床重要性,这项工作为工程高度成熟的 DENV 提供了路线图,可应用于未来的疫苗开发。我们的定向进化数据还揭示了 DENV 与其宿主和媒介之间不同的进化关系。